Literature DB >> 11242724

Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report.

E Eidelman1, G Holan, A B Fuks.   

Abstract

PURPOSE: The aim of this study was to compare the effect of mineral trioxide aggregate (MTA) to that of formocresol (FC) as pulp dressing agents in pulpotomized primary molars with carious pulp exposure.
METHODS: Forty-five primary molars of 26 children were treated by a conventional pulpotomy technique. The teeth were randomly assigned to the MTA (experimental) or FC (control) group by a toss of a coin. Following removal of the coronal pulp and hemostasis the pulp stumps were covered with an MTA paste in the experimental group. In the control group, FC was placed with a cotton pellet over the pulp stumps for 5 minutes and removed; the pulp stumps were then covered by zinc oxide-eugenol (ZOE) paste. The teeth of both groups were restored with stainless steel crowns. Eighteen children with 32 teeth arrived for clinical and radiographic follow-up evaluation ranging from 6 to 30 months.
RESULTS: The follow-up evaluations revealed only one failure (internal resorption detected at a 17 months postoperative evaluation) in a molar treated with formocresol. None of the MTA-treated teeth showed any clinical or radiographic pathology. Pulp canal obliteration was observed in 9 of 32 (28%) evaluated molars. This finding was detected in 2 out of the 15 teeth treated with FC (13%) and in 7 out of the 17 treated with MTA (41%).
CONCLUSION: MTA showed clinical and radiographic success as a dressing material following pulpotomy in primary teeth and seems to be a suitable replacement for formocresol in primary teeth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242724

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  42 in total

1.  Comparing gray mineral trioxide aggregate and diluted formocresol in pulpotomized human primary molars.

Authors:  Cameron M Zealand; Daniel M Briskie; Tatiana M Botero; James R Boynton; Jan C C Hu
Journal:  Pediatr Dent       Date:  2010 Sep-Oct       Impact factor: 1.874

2.  Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.

Authors:  C Cuadros-Fernández; A I Lorente Rodríguez; S Sáez-Martínez; J García-Binimelis; I About; M Mercadé
Journal:  Clin Oral Investig       Date:  2015-11-18       Impact factor: 3.573

Review 3.  Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.

Authors:  E Stringhini Junior; M E B Vitcel; L B Oliveira
Journal:  Eur Arch Paediatr Dent       Date:  2015-04-02

Review 4.  Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Armin Shirvani; Saeed Asgary
Journal:  Clin Oral Investig       Date:  2014-01-23       Impact factor: 3.573

5.  In vitro toxicity of grey MTA in comparison to white MTA on human periodontal ligament fibroblasts.

Authors:  S N Al-Haj Ali; S H Al-Jundi; D J Ditto
Journal:  Eur Arch Paediatr Dent       Date:  2014-07-16

6.  The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.

Authors:  Burcu Nihan Çelik; Merve Safa Mutluay; Volkan Arıkan; Şaziye Sarı
Journal:  Clin Oral Investig       Date:  2018-05-10       Impact factor: 3.573

7.  Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.

Authors:  P Juneja; S Kulkarni
Journal:  Eur Arch Paediatr Dent       Date:  2017-08-05

8.  Histopathological evaluation of pulpotomy with Er,Cr:YSGG laser vs formocresol.

Authors:  Lida Toomarian; Reza Fekrazad; Davood Sharifi; Mojdeh Baghaei; Hessam Rahimi; Behnam Eslami
Journal:  Lasers Med Sci       Date:  2007-10-24       Impact factor: 3.161

9.  Comparison of gray mineral trioxide aggregate and diluted formocresol in pulpotomized primary molars: a 6- to 24-month observation.

Authors:  John M Sushynski; Cameron M Zealand; Tatiana M Botero; James R Boynton; Robert F Majewski; Charles E Shelburne; Jan Chingchun Hu
Journal:  Pediatr Dent       Date:  2012 Sep-Oct       Impact factor: 1.874

Review 10.  Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.

Authors:  F K Ng; L B Messer
Journal:  Eur Arch Paediatr Dent       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.